22 June 2023 | News
A major advancement in overcoming India’s socio-medical challenges
LifeCell International, a stem cell banking pioneer and leading biotechnology firm headquartered in Chennai, has introduced a range of self-collection testing and preservation kits under its reproductive, sexual, women’s and baby health services.
The kits, namely SpermScore, OvaScore, and InferGenes, are primarily aimed at encouraging testing for conditions that are often stigmatised and considered taboo. Thus, right from sample collection to obtaining reports, these newly launched testing kits ensure complete privacy and convenience as they can be done entirely from the comfort of one’s personal space.
For instance, OvaScore is a female fertility hormone test that screens for 9 biomarkers to identify potential red flags, while SpermScore provides men with insight into their fertility status by testing 11 sperm health parameters and 14 sperm health conditions. SpermVault is an easy and convenient way for men, who wish to preserve their sperm for future use.
The pricing range of the kits starts from Rs 1,500 and goes up to Rs 60,000.
Other key tests that LifeCell addresses are women's health issues such as cervical cancer and menopause. In 2020, there were approximately 6,04,127 new cases of cervical cancer and 3,41,831 deaths globally, with India reporting around 21% of the total cervical cancer cases.